annual cash & cash equivalents:
$85.21M-$14.47M(-14.52%)Summary
- As of today (May 29, 2025), WGS annual cash & cash equivalents is $85.21 million, with the most recent change of -$14.47 million (-14.52%) on December 31, 2024.
- During the last 3 years, WGS annual cash & cash equivalents has fallen by -$315.36 million (-78.73%).
- WGS annual cash & cash equivalents is now -78.73% below its all-time high of $400.57 million, reached on December 31, 2021.
Performance
WGS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$99.70M+$14.49M(+17.01%)Summary
- As of today (May 29, 2025), WGS quarterly cash & cash equivalents is $99.70 million, with the most recent change of +$14.49 million (+17.01%) on March 31, 2025.
- Over the past year, WGS quarterly cash & cash equivalents has increased by +$16.03 million (+19.16%).
- WGS quarterly cash & cash equivalents is now -78.39% below its all-time high of $461.28 million, reached on September 1, 2021.
Performance
WGS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WGS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.5% | +19.2% |
| 3 y3 years | -78.7% | -68.3% |
| 5 y5 years | - | - |
WGS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.7% | at low | -68.3% | +77.8% |
| 5 y | 5-year | -78.7% | at low | -78.4% | +77.8% |
| alltime | all time | -78.7% | at low | -78.4% | +77.8% |
WGS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $99.70M(+17.0%) |
| Dec 2024 | $85.21M(-14.5%) | $85.21M(+47.2%) |
| Sep 2024 | - | $57.89M(+3.2%) |
| Jun 2024 | - | $56.08M(-33.0%) |
| Mar 2024 | - | $83.67M(-16.1%) |
| Dec 2023 | $99.68M | $99.68M(+14.1%) |
| Sep 2023 | - | $87.39M(-44.2%) |
| Jun 2023 | - | $156.66M(-22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $201.90M(+62.9%) |
| Dec 2022 | $123.93M(-69.1%) | $123.93M(-35.2%) |
| Sep 2022 | - | $191.36M(-32.8%) |
| Jun 2022 | - | $284.65M(-9.6%) |
| Mar 2022 | - | $315.00M(-21.4%) |
| Dec 2021 | $400.57M(+270.4%) | - |
| Dec 2021 | - | $400.57M(-13.2%) |
| Sep 2021 | - | $461.28M(+326.6%) |
| Dec 2020 | $108.13M | $108.13M |
FAQ
- What is GeneDx Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
- What is GeneDx Holdings quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for GeneDx Holdings?
- What is GeneDx Holdings quarterly cash & cash equivalents year-on-year change?
What is GeneDx Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of WGS is $85.21M
What is the all time high annual cash & cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high annual cash & cash equivalents is $400.57M
What is GeneDx Holdings annual cash & cash equivalents year-on-year change?
Over the past year, WGS annual cash & cash equivalents has changed by -$14.47M (-14.52%)
What is GeneDx Holdings quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of WGS is $99.70M
What is the all time high quarterly cash & cash equivalents for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash & cash equivalents is $461.28M
What is GeneDx Holdings quarterly cash & cash equivalents year-on-year change?
Over the past year, WGS quarterly cash & cash equivalents has changed by +$16.03M (+19.16%)